These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3624828)

  • 1. Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity.
    Shekim WO; Sinclair E; Glaser R; Horwitz E; Javaid J; Bylund DB
    J Child Neurol; 1987 Jan; 2(1):50-6. PubMed ID: 3624828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys.
    Shekim WO; Javaid J; Dekirmenjian H; Chapel JL; Davis JM
    Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine.
    Shekim WO; Javaid J; Davis JM; Bylund DB
    Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary 3-methyoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children.
    Brown GL; Ebert MH; Hunt RD; Rapoport JL
    Biol Psychiatry; 1981 Aug; 16(8):779-87. PubMed ID: 7197170
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine.
    Shekim WO; Dekirmenjian H; Chapel JL
    Am J Psychiatry; 1979 May; 136(5):667-71. PubMed ID: 434244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity and WISC-III profiles of Greek children with attention deficit hyperactivity disorder, learning disabilities, and language disorders.
    Filippatou DN; Livaniou EA
    Psychol Rep; 2005 Oct; 97(2):485-504. PubMed ID: 16342577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HVA and MHPG in urine of premature infants.
    Garreau B; Domenech J; Martineau J; Barthelemy C; Lelord G; Muh JP
    Psychiatry Res; 1981 Dec; 5(3):323-30. PubMed ID: 6948311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of catechol metabolites particularly MHPG in children. Relation to age, body mass indices and thyroid function.
    Popa M; Stefănescu AM; Dumitriu L
    Endocrinologie; 1986; 24(3):203-14. PubMed ID: 3775226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention deficit disorder symptoms and urine catecholamines.
    Rogeness GA; Maas JW; Javors MA; Macedo CA; Fischer C; Harris WR
    Psychiatry Res; 1989 Mar; 27(3):241-51. PubMed ID: 2469096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological correlates of urinary amine metabolites in Tourette's syndrome.
    Bornstein RA; Baker GB
    Int J Neurosci; 1988 Sep; 42(1-2):113-20. PubMed ID: 2463232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent mothers and their children: changes in maternal characteristics and child developmental and behavioral outcome at school age.
    Camp BW
    J Dev Behav Pediatr; 1996 Jun; 17(3):162-9. PubMed ID: 8783062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of urinary monoamine and metabolite output measurements in depressed patients.
    Linnoila M; Karoum F; Miller T; Potter WZ
    Am J Psychiatry; 1983 Aug; 140(8):1055-7. PubMed ID: 6191580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration.
    Kopin IJ; Bankiewicz K; Harvey-White J
    Life Sci; 1988; 43(2):133-41. PubMed ID: 3260652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of MHPG and normetanephrine in attention deficit hyperactivity disorder.
    Baker GB; Bornstein RA; Douglass AB; Van Muyden JC; Ashton S; Bazylewich TL
    Mol Chem Neuropathol; 1993; 18(1-2):173-8. PubMed ID: 8466590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of methylphenidate on urinary catecholamine excretion in hyperactivity: a partial replication.
    Zametkin AJ; Hamburger SD
    Biol Psychiatry; 1988 Feb; 23(4):350-6. PubMed ID: 3342265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary 3-methoxy-4-hydroxyphenylglycol sulfate in school children with minimal brain dysfunction syndrome].
    Wang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Feb; 18(1):45-9. PubMed ID: 3987458
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary excretion of catecholamine metabolites in hyperkinetic child syndrome.
    Khan AU; Dekirmenjian H
    Am J Psychiatry; 1981 Jan; 138(1):108-10. PubMed ID: 7446760
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine-norepinephrine interaction in hyperactive boys treated with d-amphetamine.
    Shekim WO; Dekirmenjian H; Javaid J; Bylund DB; Davis JM
    J Pediatr; 1982 May; 100(5):830-4. PubMed ID: 7069551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurochemical and neurotransmitter studies in patients with learning disabilities].
    Matsuishi T; Yamashita Y
    No To Hattatsu; 1999 May; 31(3):245-8. PubMed ID: 10355264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
    Vandel S; Vandel B; Bonin B; Camejo Z; Sandoz M; Allers G; Volmat R
    Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.